UK markets closed

Milestone Scientific, Inc. (MLSS)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.7228-0.0357 (-4.71%)
At close: 03:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 58.58M
Enterprise value 53.94M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.98
Price/book (mrq)7.85
Enterprise value/revenue 5.69
Enterprise value/EBITDA -6.86

Trading information

Stock price history

Beta (5Y monthly) 0.89
52-week change 3-26.92%
S&P500 52-week change 324.69%
52-week high 31.3500
52-week low 30.5200
50-day moving average 30.6536
200-day moving average 30.7520

Share statistics

Avg vol (3-month) 394.19k
Avg vol (10-day) 361.68k
Shares outstanding 577.23M
Implied shares outstanding 677.23M
Float 851.49M
% held by insiders 114.99%
% held by institutions 15.73%
Shares short (15 May 2024) 4415.8k
Short ratio (15 May 2024) 44.75
Short % of float (15 May 2024) 40.67%
Short % of shares outstanding (15 May 2024) 40.54%
Shares short (prior month 15 Apr 2024) 4379.38k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:3
Last split date 314 Jan 2004

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -74.50%
Operating margin (ttm)-65.15%

Management effectiveness

Return on assets (ttm)-38.25%
Return on equity (ttm)-84.99%

Income statement

Revenue (ttm)9.48M
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)-13.40%
Gross profit (ttm)N/A
EBITDA -7.17M
Net income avi to common (ttm)-7.06M
Diluted EPS (ttm)-0.1000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.01M
Total cash per share (mrq)0.06
Total debt (mrq)369.35k
Total debt/equity (mrq)4.95%
Current ratio (mrq)2.97
Book value per share (mrq)0.10

Cash flow statement

Operating cash flow (ttm)-4.54M
Levered free cash flow (ttm)-2.54M